Searched for
MODERNA
Three returnees from Ebola-hit African countries quarantined in Durg: Chhattisgarh Health Minister Shyam JaiswalChhattisgarh is fully prepared for potential virus infections. Health Minister Shyam Bihari Jaiswal assured that hospitals and quarantine f...- Women are the first caregivers in this Ebola outbreak and the most at riskEastern Congo faces a rapid Ebola outbreak. Women are primary caregivers, increasing their infection risk. Many lack protective gear, forci...
- Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...
- Moderna and other groups get $60 million to develop Ebola vaccineCEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...
- Moderna first-quarter revenue jumps on strong overseas COVID vaccine salesModerna's first-quarter revenue surpassed estimates, driven by strong international COVID-19 vaccine sales. The company forecasts lower-tha...
- Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimatesModerna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.
- OpenAI launches AI model GPT-Rosalind for life sciences researchThe GPT-Rosalind, named after 20th-century British scientist Rosalind Franklin, is designed to support research across biochemistry, drug ...
- US Stocks: Moderna rises on $2.25 billion settlement, clearing COVID vaccine patent dispute overhangModerna shares rose 9% on Wednesday after it settled a long-running legal battle over the technology that made its COVID-19 vaccine possibl...
- Moderna says FDA will consider new flu shot after resolving public disputeThe FDA will now consider Moderna's mRNA flu vaccine application after a dispute over clinical trial design. Moderna agreed to seek full ap...
- US FDA reverses course, will review Moderna's revised flu vaccine applicationThe US Food and Drug Administration will now review Moderna's influenza vaccine. This comes after an initial refusal due to trial design is...
- Moderna layoffs: U.S. Pharma giant announces massive job cuts, to have less than 5,000 employees, MRNA stocks sinkModerna had said earlier this year it expects operating costs to be between $4.7 billion and $5 billion for 2027. MRNA stock, which has los...
- Moderna open to supplying COVID vaccines to China, CEO says"We are open, we have the capacity" Bancel said about supplying its mRNA-based shots to the country, declining to say whether Moderna had s...
- Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccineModerna alleges Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before CO...
- Moderna says its low-dose COVID shots work for kids under 6Moderna's COVID-19 vaccine works in babies, toddlers and preschoolers the company announced -- and if regulators agree it could mean a chan...
- Moderna finds that inventing a COVID-19 vaccine was the easy partModerna shares plummeted on Thursday after it announced it would be able to supply only 700 million to 800 million vaccine doses this year,...
- Moderna vaccine to be available at select hospitals by Mid-JulyLast week, Indian’s drug regulator granted permission to Cipla to import donated doses of Moderna from the US. The vax doses, which are bei...
- Sanofi to produce Moderna coronavirus vaccineThe French pharmaceutical company Sanofi will help manufacture the Moderna coronavirus vaccine beginning in September, joining other compan...
- AstraZeneca has sold its stake in Moderna for more than $1 billion: The TimesAstraZeneca is retaining partnership with Moderna on other disease treatments and could sell its AstraZeneca/Oxford University COVID-19 vac...
- Moderna anticipates its COVID-19 vaccine to safeguard against new mutated coronavirus"Moderna expects that the immunity induced by its COVID-19 vaccine would be protective against coronavirus variants reported in the United ...
- Moderna extends lipids deal to boost COVID-19 vaccine outputModerna Inc has extended a deal to secure large volumes of the lipids used to produce its experimental COVID-19 vaccine in a bid to meet in...
Load More
